At HealthQuest we capture our ethos in three words: “Open + Connected + Catalytic”
For us, OPEN means being open to ideas and situations that other investors might just dismiss. As investors (and entrepreneurs) we’ve all had success with opportunities that were over-looked or rejected by others. We think that sometimes those are, in fact, the very best opportunities. We also like entrepreneurs that challenge our own paradigms about business and investing so we remain open-minded at all times.
HealthQuest is CONNECTED throughout the industry with an exceptionally broad network of established relationships with major industry players, providers and provider groups, payers, successful entrepreneurs and other investors. These relationships become an asset to our portfolio companies as we help them build bridges to potential commercial partners and collaborators, help strengthen boards and management teams, raise future capital or (when appropriate) find acquirers for our companies.
Finally, we describe ourselves as CATALYTIC because in every company we partner with we want to make a difference to the business beyond the capital invested. We look for opportunities where our experience, networks, or other contributions can fundamentally change the trajectory of the business. Every member of our team looks for catalytic opportunities with every company in our portfolio on a continuous basis – and we believe we’ve had that kind of impact on each one.
We view ourselves as a “venture growth” fund and are looking for commercial stage investments, where our capital is primarily directed towards growing revenues and scaling the company.
We are interested in learning now about companies that may not yet be at this stage, but will be in the near future. If this is the only criterion that your business does not meet please send us your business plan, so we can follow you for a future potential investment.
We invest in healthcare innovation across most of the healthcare spectrum: medical devices, diagnostics, digital health, tech enabled services, and consumer medicine. In fact, we're interested in knowing about almost any innovative and proprietary product or service in healthcare that optimizes value (lower cost plus better outcomes), reduces complexity and/or increases certainty.
We do not invest in pharmaceuticals, biotech, or healthcare-related real estate.
We look for opportunities where the product is proven, the commercial recipe for success is clear and the primary issue is properly resourcing the company. We like experienced management teams that are operating with capital-efficiency but also an urgency to build a large and profitable enterprise. We typically begin with investments of $7M-15M, with an ability to invest up to $25M over time. We prefer to lead investments and are comfortable forming syndicates. We will also consider syndicating with other lead investors.